Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603225 · ClinicalTrials.gov registry record
Transcranial Direct Current Stimulation and Autism
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 13
- Enrollment target
NCT01603225: Completed study, sponsored by Johns Hopkins University.
NCT01603225 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01603225 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities, such as speech, language and other efforts at communication in individuals with autism. In this research, battery powered device is used to deliver very weak electrical current to the surface of the scalp while participants are involved in tasks aimed at training or measuring communicative efforts, speech, language or related cognitive functions. Our aim is to find out whether tDCS will improve these mental abilities.
Interventions
- PROCEDURE Transcranial Direct Current Stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-10 |
| Est. Completion | 2023-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01603225
The ClinicalTrials.gov registry entry for NCT01603225 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT01603225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01603225 about?
NCT01603225 is a clinical study titled "Transcranial Direct Current Stimulation and Autism". This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities, such as speech, language and other efforts at communication in individuals with autism. In this research, battery powered device is used to deliver very weak electri...
What is the current status of trial NCT01603225?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2023-02-21.
What interventions are being tested in trial NCT01603225?
The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (PROCEDURE).
Who is sponsoring clinical trial NCT01603225?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.